No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ALEC240719C5000
- 0.90
- +0.20+28.57%
15min DelayClose Jul 12 15:59 ET
0.90High0.40Low
0.40Open0.70Pre Close7 Volume170 Open Interest5.00Strike Price580.00Turnover128.35%IV6.50%PremiumJul 19, 2024Expiry Date0.54Intrinsic Value100Multiplier6DDays to Expiry0.36Extrinsic Value100Contract SizeAmericanOptions Type0.7524Delta0.3281Gamma7.91Leverage Ratio-0.0238Theta0.0006Rho5.95Eff Leverage0.0024Vega
Intraday
- 5D
- Daily
News
Strong Week for Alector (NASDAQ:ALEC) Shareholders Doesn't Alleviate Pain of Three-year Loss
It's nice to see the Alector, Inc. (NASDAQ:ALEC) share price up 23% in a week. But the last three years have seen a terrible decline. Indeed, the share price is down a whopping 84% in the last
Why Did Analysts Give Alector, Inc. (ALEC) a Moderate Buy Rating?
Barclays Maintains Alector(ALEC.US) With Buy Rating, Maintains Target Price $12
Barclays analyst Carter Gould maintains $Alector(ALEC.US)$ with a buy rating, and maintains the target price at $12.According to TipRanks data, the analyst has a success rate of 54.4% and a total aver
H.C. Wainwright Maintains Alector(ALEC.US) With Buy Rating, Maintains Target Price $35
H.C. Wainwright analyst Andrew Fein maintains $Alector(ALEC.US)$ with a buy rating, and maintains the target price at $35.According to TipRanks data, the analyst has a success rate of 46.9% and a tota
Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
SOUTH SAN FRANCISCO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (NASDAQ:ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a
Express News | HC Wainwright & Co. Reiterates Buy on Alector, Maintains $35 Price Target
Comments
Alector's low P/S ratio may be due to poor revenue performance and expectations of this trend continuing. Future revenue growth is expected to be significantly lower than the industry, possibly causing discomfort among shareholders and a drop in share price.
Little Excitement Around Alector, Inc.'s (NASDAQ:ALEC) Revenues As Shares Take 27% PoundingArnon Rosenthal's major sale indicates insiders may expect a lower price. Despite high insider ownership, the absence of insider purchases and significant sales stirs uncertainty about the company's prospects and arouses investor caution.
Despite declining revenue, Alector's cash runway looks promising. However, significant cash burn could necessitate capital raise, potentially diluting shareholder value. Risk factors warrant careful scrutiny before investment.
$Applied Optoelectronics(AAOI.US$ $Adobe(ADBE.US$ $Alector(ALEC.US$ $AMC Entertainment(AMC.US$ $BigCommerce Holdings(BIGC.US$ $Disney(DIS.US$ $Expedia(EXPE.US$ $Hilton Worldwide(HLT.US$ $Rubicon Technologies(RBT.US$ $ResMed(RMD.US$ $Six Flags Entertainment(SIX.US$ $Save Foods(SVFD.US$ $Tivic Health Systems(TIVC.US$ $Tupperware Brands(TUP.US$ $Wix.com(WIX.US$ $Wynn Resorts(WYNN.US$
1
1
Read more